Summit Global Investments’s Orthofix Medical OFIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
– Sell
-12,412
Closed -$538K – 609
2021
Q1
$538K Buy
+12,412
New +$547K 0.03% 330
2019
Q4
– Sell
-15,600
Closed -$827K – 293
2019
Q3
$827K Buy
15,600
+3,900
+33% +$201K 0.1% 177
2019
Q2
$619K Buy
+11,700
New +$622K 0.08% 255
2019
Q1
– Sell
-13,200
Closed -$693K – 300
2018
Q4
$693K Sell
13,200
-200
-1% -$11.4K 0.11% 143
2018
Q3
$775K Buy
13,400
+1,600
+14% +$89.7K 0.1% 176
2018
Q2
$670K Buy
11,800
+1,600
+16% +$91.1K 0.1% 169
2018
Q1
$600K Buy
+10,200
New +$571K 0.1% 142

Other funds holding OFIX

Summit Global Investments's OFIX Position: Q2 2021 in Review

Summit Global Investments sold out of Orthofix Medical (OFIX) in Q2 2021, closing a stake of 12,412 shares — an estimated $538K sold.

Summit Global Investments first reported a position in OFIX in Q1 2018 and held it in 7 quarters. The position peaked at $827K in Q3 2019. 134 funds tracked by Wall St. Rank hold OFIX as of Q2 2021.

  • Summit Global Investments reported no remaining Orthofix Medical position as of Q2 2021 after selling out during the quarter.
  • Summit Global Investments sold 12,412 Orthofix Medical shares in Q2 2021, an estimated $538K.
  • Summit Global Investments first reported a position in Orthofix Medical in Q1 2018 and held it in 7 quarters.
  • Summit Global Investments's Orthofix Medical position peaked at $827K in Q3 2019.
  • 134 funds tracked by Wall St. Rank held Orthofix Medical as of Q2 2021.

Based on Summit Global Investments's 13F filing for Q2 2021, filed 28 Jan 2022.